Marshall Wace North America’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.66M Sell
5,876
-154,056
-96% -$50.5M 0.01% 774
2021
Q2
$55.4M Sell
159,932
-20,267
-11% -$6.14M 0.23% 91
2021
Q1
$50.4M Sell
180,199
-182,683
-50% -$49.3M 0.21% 116
2020
Q4
$88.9M Buy
362,882
+221,548
+157% +$57.2M 0.4% 50
2020
Q3
$40.1M Buy
141,334
+139,527
+7,721% +$38.9M 0.26% 97
2020
Q2
$483K Sell
1,807
-102,350
-98% -$30.8M ﹤0.01% 929
2020
Q1
$33M Sell
104,157
-11,035
-10% -$3.35M 0.25% 114
2019
Q4
$34.2M Buy
+115,192
New +$32M 0.16% 152
2019
Q1
Sell
-23,179
Closed -$6.97M 1563
2018
Q4
$6.97M Sell
23,179
-183,589
-89% -$58.6M 0.07% 202
2018
Q3
$73.1M Buy
+206,768
New +$71.2M 0.5% 51
2018
Q2
Sell
-100,027
Closed -$27.4M 1395
2018
Q1
$27.4M Sell
100,027
-155,971
-61% -$48.4M 0.14% 169
2017
Q4
$81.6M Buy
255,998
+16,582
+7% +$5.32M 0.45% 44
2017
Q3
$74.9M Sell
239,416
-14,608
-6% -$4.33M 0.48% 33
2017
Q2
$68.8M Buy
254,024
+113,315
+81% +$30M 0.5% 39
2017
Q1
$38.4M Buy
+140,709
New +$39.8M 0.3% 93
2013
Q4
$7.97M Buy
+28,487
New +$7.37M 0.17% 141

Other funds holding BIIB